ForaCare Suisse AG Releases Rapid COVID-19 Antigen Test

Test Results in 15 Minutes, No Laboratory Processing Required, Highly Accurate & Reliable Results

ST. GALLEN, Switzerland, January 7, 2021 /PRNewswire/ — ForaCare Suisse AG announced today the release of its FORA COVID-19 Rapid Test that provides fast, accurate and easy-to-interpret test results. The test can be administered by trained professionals without requiring or waiting on laboratory-processed results.

Approved by Swissmedic, the FORA COVID-19 Rapid Test is a diagnostic antigen test for the direct detection of an acute infection with SARS-CoV-2, the respiratory virus caused by the novel coronavirus with results in just 15 minutes. The test kit packaging comes with everything necessary for administering a test for COVID-19 antigen and/or antibody and can determine if a person has an active COVID-19 infection, as well as whether a person has had and recovered from a COVID-19 infection.

The rapid test has been approved for distribution in Switzerland and its treaty countries without restriction. It is listed by the Federal Institute for Drugs and Medical Devices (BfArM) and is reimbursable in Germany.

“During the COVID-19 crisis, obtaining testing has been complicated and often requires professionals to rely on outside laboratories to make the determination of active virus,” said Ty-Minh Tan, CEO of ForaCare Suisse AG. “We are proud to offer trained testing professionals an alternative that allows them to make fast, accurate and reliable tests and get results in minutes, not days, without having to rely on a laboratory to process the tests.”

The FORA COVID-19 Rapid Test is ForaCare’s newest professional product offering that enables trained professionals to administer a COVID-19 test and results that can be easily interpreted without the need to send to a laboratory for processing. The administrator can test a patient quickly and easily by following five simple steps with graphics and guidance included in each test kit. Because there is no laboratory required, testing professionals can make the determination of active infection or existence of antibody quickly and easily.

The sample material for the test is obtained by a nasopharyngeal swab and can detect the virus in just 15 minutes. Recent clinical study results demonstrated the FORA COVID-19 Rapid Test is accurate and reliable with 91.3% sensitivity and 98.6% specificity. For more information, visit https://africa.foracare.ch/covid-19-antigen-rapid-test/

ForaCare’s FORA COVID-19 Rapid Test was developed via a collaboration with Taiwan Academia Sinica, ranked by Reuter as one of the Top 20 “World’s Most Innovative Research Institutions”1. Recent clinical study results demonstrated the FORA COVID-19 Rapid Test is accurate and reliable with a 95.8% sensitivity (Ct≤30) and a 98.6% specificity by testing 57 PCR-positive and 80 PCR-negative specimens.

ForaCare supplies Swiss quality innovative products to the international healthcare market that empower people to improve their health. Providing highly reliable and much-needed healthcare technologies, such as diabetes monitors, thermometers, blood pressure monitors and pulse oximeters, has never been more important than during the worldwide pandemic by allowing consumers to accurately monitor important health parameters at home.

  1. Ewalt, David M. (2019, September 18). The World’s Most Innovative Research Institutions 2019. Retrieved November 26, 2020, from http://www.reuters.com/innovation/most-innovative-institutions-2019

Contact: Elena Birrer
+41-71-220-1001
E-mail:
Website: http://www.foracare.ch/